Cleared Traditional

K222450 - LVIS NeuroMatch (FDA 510(k) Clearance)

Jun 2023
Decision
298d
Days
Class 2
Risk

K222450 is an FDA 510(k) clearance for the LVIS NeuroMatch. This device is classified as a Automatic Event Detection Software For Full-montage Electroencephalograph (Class II - Special Controls, product code OMB).

Submitted by LVIS Corporation (Palo Alto, US). The FDA issued a Cleared decision on June 9, 2023, 298 days after receiving the submission on August 15, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User.

Submission Details

510(k) Number K222450 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2022
Decision Date June 09, 2023
Days to Decision 298 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OMB - Automatic Event Detection Software For Full-montage Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User